Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • cd4 cell count (1)
  • cohort (1)
  • copies (1)
  • count cells (1)
  • female (1)
  • humans (1)
  • insomnia (1)
  • living (4)
  • lymphocyte (1)
  • men (2)
  • poor sleep (2)
  • questionnaires (4)
  • sleep (11)
  • wake (1)
  • Sizes of these terms reflect their relevance to your search.

    Studies conducted in people living with HIV (PLHIV) report high rates of sleep disturbance, without a clear explanation as to cause or effect. Therefore, we proposed use of multiple validated questionnaires that would allow a more comprehensive evaluation of sleep quality in PLHIV. We administered eight validated sleep and wellbeing questionnaires, recording different aspects of sleep in order to provide a comprehensive description of sleep quality, quantity, daytime functioning, wakefulness, and general wellbeing. Associations with demographics and clinical data were analyzed by univariable/multivariable analyses. Of 254 subjects 99% were male (98% men who have sex with men), 88% white, mean age 41 (SD ± 9.9) years, HIV duration eight years (SD ± 6.3), 94% were on antiretroviral therapy, mean CD4 cell count was 724 cells/mm3, 81% had HIV RNA<40 copies/ml, 72% were university educated, and 60% used 'chemsex' drugs. Almost half (45%) reported poor sleep quality, 22% insomnia, 21% daytime sleepiness, and 33% fatigue. As individual factors, HIV duration ≥10 years, anxiety, depression, and recreational drug use were associated with poor quality sleep, fatigue, and poorer functional outcomes (p ≤ 0.05). The prevalence of sleep disturbance was high in our cohort of PLHIV. Sleep disturbance was associated with longer duration of HIV infection, depression, anxiety, and recreational drug use.

    Citation

    Ana Milinkovic, Suveer Singh, Bryony Simmons, Anton Pozniak, Marta Boffito, Nneka Nwokolo. Multimodality assessment of sleep outcomes in people living with HIV performed using validated sleep questionnaires. International journal of STD & AIDS. 2020 Sep;31(10):996-1003

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32772688

    View Full Text